APA (7th ed.) Citation

S, L., BS, S., U, S., VK, S., LMC, E., C, K., . . . S, H. (2020). Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer. Scientific reports, 10(1), 14380. https://doi.org/10.1038/s41598-020-71263-9

Chicago Style (17th ed.) Citation

S, Luszczak, et al. "Co-targeting PIM and PI3K/mTOR Using Multikinase Inhibitor AUM302 and a Combination of AZD-1208 and BEZ235 in Prostate Cancer." Scientific Reports 10, no. 1 (2020): 14380. https://doi.org/10.1038/s41598-020-71263-9.

MLA (9th ed.) Citation

S, Luszczak, et al. "Co-targeting PIM and PI3K/mTOR Using Multikinase Inhibitor AUM302 and a Combination of AZD-1208 and BEZ235 in Prostate Cancer." Scientific Reports, vol. 10, no. 1, 2020, p. 14380, https://doi.org/10.1038/s41598-020-71263-9.